Steris | STE - Current Liabilities


Steris reported $1.21B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
3M USD 11.87B 489M Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
CONMED USD 458.96M 3.56M Sep/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
Dexcom USD 2.25B 105.1M Sep/2026
Ecolab USD 6.38B 393.2M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Fortive USD 1.29B 800K Sep/2026
Getinge SEK 12.03B 3.01B Jun/2026
Globus Medical USD 507.94M 28.59M Sep/2026
Haemonetics USD 300.84M 37.6M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
J&J USD 55.46B 562M Sep/2026
Olympus JPY 391.7B 75.68B Sep/2026
Orthofix International USD 138.38M 18.62M Sep/2026
Owens Minor USD 671.5M 5.28M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
Steris USD 1.21B 75.5M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026